BACKGROUND: A previously developed, specific, rapid-format immunochromatographic card test that detects immunoglobulin G4 to the recombinant Onchocerca volvulus antigen Ov-16 was modified to detect antibodies in whole blood. METHODS: Ov-16 card test results were assessed in 1511 subjects > or =2 years of age in 7 West African villages with varying histories of onchocerciasis control measures. RESULTS: In villages in which control measures had been implemented, anti-Ov-16 antibody prevalence rates ranged from 5.2% to 65.1%. Antibody prevalence rates were close to zero among subjects born after effective control measures had been implemented. In 2 villages without a history of control measures where onchocerciasis was endemic, microfilariae (MF) prevalence rates were 82.8% and 65.1%, and antibody prevalence rates were 73.1% and 62.1%. In these 2 villages, the sensitivity of the Ov-16 card test was 81.1% and 76.5%, the specificity was 100%, and the positive predictive value was 91.8% and 80.5%. MF and antibody prevalence rates were correlated (Spearman's r=0.815; P<.038). CONCLUSIONS: The Ov-16 card test is field applicable, exhibits high sensitivity and specificity for O. volvulus infection, and has great potential as a tool for surveillance and for evaluating the success of onchocerciasis control measures.
BACKGROUND: A previously developed, specific, rapid-format immunochromatographic card test that detects immunoglobulin G4 to the recombinant Onchocerca volvulus antigen Ov-16 was modified to detect antibodies in whole blood. METHODS: Ov-16 card test results were assessed in 1511 subjects > or =2 years of age in 7 West African villages with varying histories of onchocerciasis control measures. RESULTS: In villages in which control measures had been implemented, anti-Ov-16 antibody prevalence rates ranged from 5.2% to 65.1%. Antibody prevalence rates were close to zero among subjects born after effective control measures had been implemented. In 2 villages without a history of control measures where onchocerciasis was endemic, microfilariae (MF) prevalence rates were 82.8% and 65.1%, and antibody prevalence rates were 73.1% and 62.1%. In these 2 villages, the sensitivity of the Ov-16 card test was 81.1% and 76.5%, the specificity was 100%, and the positive predictive value was 91.8% and 80.5%. MF and antibody prevalence rates were correlated (Spearman's r=0.815; P<.038). CONCLUSIONS: The Ov-16 card test is field applicable, exhibits high sensitivity and specificity for O. volvulus infection, and has great potential as a tool for surveillance and for evaluating the success of onchocerciasis control measures.
Authors: Mario A Rodríguez-Pérez; Thomas R Unnasch; Alfredo Domínguez-Vázquez; Alba L Morales-Castro; Graciela P Peña-Flores; María E Orozco-Algarra; Juan I Arredondo-Jiménez; Frank Richards; Miguel A Vásquez-Rodríguez; Vidal García Rendón Journal: Am J Trop Med Hyg Date: 2010-07 Impact factor: 2.345
Authors: Moses Katabarwa; Tom Lakwo; Peace Habomugisha; Stella Agunyo; Edson Byamukama; David Oguttu; Richard Ndyomugyenyi; Ephraim Tukesiga; Galex Orukan Ochieng; Francis Abwaimo; Ambrose Onapa; Dennis W K Lwamafa; Frank Walsh; Thomas R Unnasch; Frank O Richards Journal: Am J Trop Med Hyg Date: 2014-03-31 Impact factor: 2.345
Authors: Mario A Rodríguez-Pérez; Thomas R Unnasch; Alfredo Domínguez-Vázquez; Alba L Morales-Castro; Frank Richards; Graciela P Peña-Flores; María Eugenia Orozco-Algarra; Gibert Prado-Velasco Journal: Am J Trop Med Hyg Date: 2010-07 Impact factor: 2.345
Authors: Heather N Paulin; Andreas Nshala; Akili Kalinga; Upendo Mwingira; Ryan Wiegand; Vitaliano Cama; Paul T Cantey Journal: Am J Trop Med Hyg Date: 2017-07-19 Impact factor: 2.345
Authors: Larry W Chang; Megan E Reller; Justin A Bishop; Kawsar Talaat; Thomas B Nutman; Paul G Auwaerter Journal: Clin Infect Dis Date: 2008-07-01 Impact factor: 9.079
Authors: Peter D Burbelo; Roshan Ramanathan; Amy D Klion; Michael J Iadarola; Thomas B Nutman Journal: J Clin Microbiol Date: 2008-05-28 Impact factor: 5.948
Authors: Jessica L Prince-Guerra; Vitaliano A Cama; Nana Wilson; Elizabeth A Thiele; Josias Likwela; Nestor Ndakala; Jacques Muzinga Wa Muzinga; Nicholas Ayebazibwe; Yassa D Ndjakani; Naomi A Pitchouna; Dieudonne Mumba; Antoinette K Tshefu; Guilherme Ogawa; Paul T Cantey Journal: Am J Trop Med Hyg Date: 2018-03-29 Impact factor: 2.345